These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20980914)

  • 21. Markers of T Cell Exhaustion and Senescence and Their Relationship to Plasma TGF-β Levels in Treated HIV+ Immune Non-responders.
    Shive CL; Freeman ML; Younes SA; Kowal CM; Canaday DH; Rodriguez B; Lederman MM; Anthony DD
    Front Immunol; 2021; 12():638010. PubMed ID: 33868264
    [No Abstract]   [Full Text] [Related]  

  • 22. Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
    Horta A; Nobrega C; Amorim-Machado P; Coutinho-Teixeira V; Barreira-Silva P; Boavida S; Costa P; Sarmento-Castro R; Castro AG; Correia-Neves M
    PLoS One; 2013; 8(2):e57336. PubMed ID: 23437372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In HIV-infected patients, some differential alterations of CD4 and CD8 T cell homeostasis may not be restored by ≥ 7 years of highly active antiretroviral therapy, in spite of good CD4 T cell repopulation.
    Bordoni V; Agrati C; Rinaldi A; Viola D; De Simone G; Gioia C; Martini F
    J Antimicrob Chemother; 2012 Jul; 67(7):1802-4. PubMed ID: 22461310
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
    Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
    J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.
    Ssewanyana I; Baker CA; Ruel T; Bousheri S; Kamya M; Dorsey G; Rosenthal PJ; Charlebois E; Havlir D; Cao H
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):65-71. PubMed ID: 19182922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L; Siegel J; Spritzler J; Pottage J; Agnoli M; Landay A
    AIDS; 2000 May; 14(7):761-70. PubMed ID: 10839583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.
    Hatano H; Jain V; Hunt PW; Lee TH; Sinclair E; Do TD; Hoh R; Martin JN; McCune JM; Hecht F; Busch MP; Deeks SG
    J Infect Dis; 2013 Jul; 208(1):50-6. PubMed ID: 23089590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.
    Méndez-Lagares G; García-Pergañeda A; del Mar del Pozo-Balado M; Genebat M; Ruiz-Mateos E; García García M; Muñoz-Fernández MÁ; Pacheco YM; Leal M
    J Antimicrob Chemother; 2012 May; 67(5):1228-37. PubMed ID: 22287235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between recent thymic emigrants and CD4+ T-cell recovery after short-term antiretroviral therapy initiation.
    Briceño O; Chávez-Torres M; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Pinto-Cardoso S; Reyes-Terán G
    AIDS; 2020 Mar; 34(4):501-511. PubMed ID: 31794524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
    Piconi S; Parisotto S; Rizzardini G; Passerini S; Terzi R; Argenteri B; Meraviglia P; Capetti A; Biasin M; Trabattoni D; Clerici M
    Blood; 2011 Sep; 118(12):3263-72. PubMed ID: 21576701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged Antiretroviral Therapy in Adolescents With Vertical HIV Infection Leads to Different Cytokine Profiles Depending on Viremia Persistence.
    Munhoz LGC; Garcia Spina F; Machado DM; Gouvea A; Succi RCM; Diaz RS; De Moraes-Pinto MI
    Pediatr Infect Dis J; 2019 Nov; 38(11):1115-1120. PubMed ID: 31626046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
    Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
    HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Day CL; Kaufmann DE; Kiepiela P; Brown JA; Moodley ES; Reddy S; Mackey EW; Miller JD; Leslie AJ; DePierres C; Mncube Z; Duraiswamy J; Zhu B; Eichbaum Q; Altfeld M; Wherry EJ; Coovadia HM; Goulder PJ; Klenerman P; Ahmed R; Freeman GJ; Walker BD
    Nature; 2006 Sep; 443(7109):350-4. PubMed ID: 16921384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
    Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.
    Muenchhoff M; Adland E; Roider J; Kløverpris H; Leslie A; Boehm S; Keppler OT; Ndung'u T; Goulder PJR
    J Infect Dis; 2019 Apr; 219(9):1407-1417. PubMed ID: 30624717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.
    Antonelli LR; Mahnke Y; Hodge JN; Porter BO; Barber DL; DerSimonian R; Greenwald JH; Roby G; Mican J; Sher A; Roederer M; Sereti I
    Blood; 2010 Nov; 116(19):3818-27. PubMed ID: 20660788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy.
    Macatangay BJC; Gandhi RT; Jones RB; Mcmahon DK; Lalama CM; Bosch RJ; Cyktor JC; Thomas AS; Borowski L; Riddler SA; Hogg E; Stevenson E; Eron JJ; Mellors JW; Rinaldo CR;
    AIDS; 2020 Jan; 34(1):15-24. PubMed ID: 31634201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.